Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 82009-004

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 82009-004). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-01 (Figure 01)

A line graph depicting cumulative incidence (%) over time in years comparing Atorvastatin and Placebo. The solid line represents Atorvastatin, and the dashed line represents Placebo, showing lower incidence for Atorvastatin. The graph includes a hazard ratio (HR=0.64) and a p-value (0.0005) indicating statistical significance.*

FDA Label Image

Figure-02 (Figure 02)

A line graph comparing cumulative hazard percentages over time between Atorvastatin and placebo groups. The x-axis shows time in years up to 5 years, and the y-axis shows cumulative hazard percentage. The chart includes a hazard ratio (HR) with confidence interval and p-value, illustrating risk reduction with Atorvastatin during follow-up.*

FDA Label Image

Figure-03 (Figure 03)

A line graph showing the percentage of subjects experiencing a major cardiovascular event over a 5-year period for Atorvastatin 10 mg and 80 mg. The x-axis represents time to first major cardiovascular endpoint (years), and the y-axis reflects the percentage of subjects. The graph compares the two dosages, with 10 mg represented by a dashed line and 80 mg by a solid line, showing the hazard ratio and statistical significance (HR 0.78; P=0.0002).*

FDA Label Image

Btl-lbl-10mg-90s (Btl Lbl 10mg 90s)

Label for Atorvastatin Calcium Tablets, USP 10 mg, film-coated oral tablets. The bottle contains 90 tablets with NDC 82009-001-90. The product is manufactured by Apotex Inc. and labeled by Quallent Pharmaceuticals. Storage instructions and dosing directions reference the package insert.*

FDA Label Image

Btl-lbl-20mg-1000s (Btl Lbl 20mg 1000s)

Label for Atorvastatin Calcium Tablets USP, 20 mg, film-coated tablets in a bottle of 1,000 count. The label includes storage instructions and specifies prescription use only. Manufactured by Apotex Inc. and labeled for Quallent Pharmaceuticals.*

FDA Label Image

Btl-lbl-40mg-1000s (Btl Lbl 40mg 1000s)

Label for Atorvastatin Calcium Tablets, USP 40 mg by Quallent Pharmaceuticals. The label indicates 1,000 tablets in the package with a NDC of 82009-003-10. It includes storage instructions and notes the product is for prescription use only. Manufacturer details include Apotex Inc. in Canada and Quallent in Grand Cayman.*

FDA Label Image

Btl-lbl-80mg-1000s (Btl Lbl 80mg 1000s)

Label for Atorvastatin Calcium Tablets, USP 80 mg film-coated tablets by Quallent Pharmaceuticals. The label indicates a package containing 1,000 tablets, bearing the NDC 82009-004-10. It notes the product is prescription only and includes storage instructions and manufacturer information from Apotex Inc. in Toronto, Canada, with manufacturing for Quallent in George Town, Grand Cayman.*

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure of atorvastatin calcium, illustrating the molecular arrangement of the atorvastatin compound complexed with calcium ions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.